Suchergebnisse - "Ungaro, Ryan C"

PubPharm (14)

1

Early Ileocecal Resection for Crohn's Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy : A Population-Based Cohort Study

enthalten in: Gastroenterology | 2023

von Agrawal, M. | Ebert, A. | Poulsen, G. | +5

2

Second-Line Biologic Therapy Following Tumor Necrosis Factor Antagonist Failure : A Real-World Propensity Score-Weighted Analysis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Ibing, S. | Cho, J. | Böttinger, E. | +1

3

Comparison of Disease Phenotype and Course among Elderly- and Early-Onset Inflammatory Bowel Diseases in the Middle East

enthalten in: Archives of Iranian medicine | 2023

von Vosoghinia, H. | Saberzadeh-Ardestani, B. | Anushiravani, A. | +22

4

Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy : A Multi-Center Cohort Study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Holmer, A. | Luo, J. | Russ, K. | +22

5

Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab

enthalten in: Digestive diseases and sciences | 2022

von Costable, N. | Borman, Z. | Ji, J. | +2

6

Impact of thiopurine discontinuation at anti-tumour necrosis factor initiation in inflammatory bowel disease treatment : a nationwide Danish cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Thomsen, S. | Ungaro, R. | Allin, K. | +5

CommentIn: Aliment Pharmacol Ther. 2022 Mar;55(6):750-751. - PMID 35245960

7

Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases

enthalten in: The American journal of gastroenterology | 2022

von Kappelman, M. | Weaver, K. | Zhang, X. | +20

CommentIn: Am J Gastroenterol. 2022 Aug 1;117(8):1329. - PMID 35435853

8

Outcomes of COVID-19 in Patients with Inflammatory Bowel Disease : Comparison with Household Members and the Role of IBD Medications

enthalten in: Archives of Iranian medicine | 2022

von Sima, A. | Saberzadeh-Ardestani, B. | Vahedi, H. | +21

9

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

enthalten in: JAMA network open | 2021

von Izadi, Z. | Brenner, E. | Mahil, S. | +164

CommentIn: JAMA Netw Open. 2021 Oct 1;4(10):e2129707. - PMID 34661668

10

Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry

enthalten in: Journal of Crohn's & colitis | 2021

von Agrawal, M. | Brenner, E. | Zhang, X. | +14